Singulex Launches Clarity Clostridioides difficile Toxin A/B Assay
The new test is a high-sensitivity, high-precision, single-test solution for the diagnosis of true Clostridioides difficile infection.
Read MorePosted by Steve Halasey | Nov 14, 2018 | Immunoassay, Research |
The new test is a high-sensitivity, high-precision, single-test solution for the diagnosis of true Clostridioides difficile infection.
Read MorePosted by Steve Halasey | Nov 13, 2018 | Cancer, Molecular Diagnostics, Research |
The test challenges a $100 million annual US laboratory market by reducing costs through a simple, screening assay.
Read MorePosted by Steve Halasey | Nov 13, 2018 | Molecular Diagnostics |
The new molecular diagnostic enables the direct detection of varicella-zoster virus DNA from cerebrospinal fluid.
Read MorePosted by Steve Halasey | Nov 9, 2018 | Disease States, Leukemia, Lymphoma, Molecular Diagnostics |
Droplet digital PCR can provide a more accurate assessment of low levels of BCR-ABL mRNA than quantitative real-time PCR.
Read MorePosted by Steve Halasey | Nov 7, 2018 | Melanoma |
The partners will apply deep machine learning to develop biomarker models for relevant treatment-associated endpoints such as immune-related adverse events, clinical response, or survival.
Read More